Excited to share that our new paper about moderate and severe activity definitions in #RELESSER is out now and available online! 🎉
Read it here 👉 https://t.co/nb4tqvNIJY
🔥 Knowing what to do for peripheral nervous system involvement in systemic autoimmune diseases like #Sjogrens#SLE#lupus is challenging. We now have evidence-based guidelines that will help health care providers take better care of patients worldwide!
https://t.co/4gl1qi2WNi
Thank you @SjogrensOrg
✅ The American College of Rheumatology (ACR) officially released its updated Guideline for the Treatment of Systemic #Lupus Erythematosus (SLE)
Link to FULL MANUSCRIPT: https://t.co/l71QWUL3wN
Los asistentes al XXIII Congreso Nacional de LUPUS ya tienen su ejemplar, y TÚ podrás tenerlo desde https://t.co/sLQY0tQZgy / El Lupus / Documentos.
Enlace ▶️ https://t.co/L2bMA8SGhY
❗️MANUAL que ayudará principalmente a personas afectadas por #lupus , pero .... ⬇️🧵⬇️🧵⬇️
El Lupus tiene síntomas muy diversos y diferentes en cada paciente.
Dra. Irene Altabás hace un repaso sobre el #lupus ¿qué es? tipos, síntomas
#CongresoLupus25#PacienteInformado
🚨🚨🚨 AHHH we have just been granted a 🔓 FREE 50-DAY ACCESS LINK to the expert #consensus on the therapeutic management of RARE systemic #lupus erythematosus manifestations
Can you please re-tweet the link so that a MAXIMUM have access for free 🔄 LINK: https://t.co/wNrq1i2Cms
Glad to be at @LupusCongress in Toronto presenting our poster from the @RELES_SER cohort about new proposal for definition of moderate and severe disease activity.
Full paper coming soon!
🎤 Presenting our multicentre study on lupus nephritis today at #LUPUS2025 !
Excited to share key findings & collaborate with experts in the field. Grateful to our team & partners for making this research possible. @reuma_hub@irealt2@BeaFrade@DrGomezPuerta@LupusCongress
I’m very happy to be at @LupusCongress in Toronto, presenting the results of our study “Bridging the gap between patient's perception on quality of life and disease activity and damage in systemic lupus erythematosus patient.”
#LUPUS2025
@DrRiveraRedondo ⚪️ Entre las comunicaciones orales del 51° Congreso de la SER, en la mesa de #lupus, la Dra. @irealt2, del Complexo Hospitalario Universitario de #Vigo, ha presentado los datos del estudio del Registro BEl-SPAIN sobre el uso temprano de biológicos. ⬇️⬇️
#SER2025
Now published simultaneously in AC&R + A&R, the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis
See ACR guideline page for resources - https://t.co/zhvkPxCTcr
DOI link - https://t.co/Hllq83J7Kc
Download the article - https://t.co/uAJ7JaO7pz
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
⏩HDXQ, azathioprine, AZA, sulfa, TNFi: safe
⏩MTX, myc, and cyclophosphamide: teratogenic
⏩Early counseling and shared decision-making
https://t.co/FpChzz66s0
🆕 ¡Estrenamos nuevo programa en nuestro canal de podcast junto a @JOVREUM!
🗣️ Estos jóvenes especialistas en #Reumatología: @Pablomc1996@cristianasieiro@drjsequirheum@Belen_Miguel_, nos acercan la especialidad desde una nueva perspectiva, dan a conocer este grupo de trabajo, además descubrimos datos curiosos que sorprenderán a cualquiera. 😯
🎧 ¡No te lo pierdas! Escúchalo ya en nuestro canal. 🎙️ https://t.co/q8Q0A4POwE
🎉 No vemos mejor modo de celebrar el #DíaDeLaMujer#8M q difundiendo el Libro Blanca sobre Salud y Género, d @OdSalud y @EstComunicacion.
👏 Nuestra más sincera enhorabuena a la Dra @irealt2 por el magistral capítulo d #lupus con el q ha contribuido a esta importante obra